VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q39048231 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000227.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q39048231‏
024 ‎‡a 0000-0003-4410-6635‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q39048231‏
100 0 ‎‡a Richard G White‏ ‎‡9 ast‏ ‎‡9 it‏ ‎‡9 sl‏ ‎‡9 es‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a রিচার্ড জি হোয়াইট‏ ‎‡c গবেষক‏ ‎‡9 bn‏
400 0 ‎‡a Richard G White‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Richard G White‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease Burden‏
670 ‎‡a Author's A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis‏
670 ‎‡a Author's A network-level explanation for the differences in HIV prevalence in South Africa's racial groups‏
670 ‎‡a Author's A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data.‏
670 ‎‡a Author's Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings‏
670 ‎‡a Author's Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention‏
670 ‎‡a Author's Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study‏
670 ‎‡a Author's Amplified HIV Transmission during Early‐Stage Infection‏
670 ‎‡a Author's An evaluation of tuberculosis contact investigations against national standards‏
670 ‎‡a Author's An explanation for the low proportion of tuberculosis that results from transmission between household and known social contacts.‏
670 ‎‡a Author's Antiretroviral therapy and sexual behavior in Uganda: a cohort study‏
670 ‎‡a Author's Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methods‏
670 ‎‡a Author's Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa‏
670 ‎‡a Author's Attaining realistic and substantial reductions in HIV incidence: model projections of combining microbicide and male circumcision interventions in rural Uganda‏
670 ‎‡a Author's Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of historical changes in risk behaviour and male circumcision‏
670 ‎‡a Author's Bayesian history matching of complex infectious disease models using emulation: a tutorial and a case study on HIV in Uganda‏
670 ‎‡a Author's Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau‏
670 ‎‡a Author's Calibrating models in economic evaluation: a seven-step approach.‏
670 ‎‡a Author's Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study‏
670 ‎‡a Author's Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study‏
670 ‎‡a Author's Choice of time horizon critical in estimating costs and effects of changes to HIV programmes.‏
670 ‎‡a Author's Commentary: What can we make of an association between human immunodeficiency virus prevalence and population mobility?‏
670 ‎‡a Author's Community understanding of Respondent-Driven Sampling in a medical research setting in Uganda: importance for the use of RDS for public health research‏
670 ‎‡a Author's Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors.‏
670 ‎‡a Author's Concurrency is more complex than it seems‏
670 ‎‡a Author's Correction to: Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study‏
670 ‎‡a Author's Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis‏
670 ‎‡a Author's Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models‏
670 ‎‡a Author's Coverage of clinic-based TB screening in South Africa may be low in key risk groups.‏
670 ‎‡a Author's Determinants of coital frequency among married women in Central African Republic: the role of female genital cutting‏
670 ‎‡a Author's Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa?‏
670 ‎‡a Author's Does the 'inverse equity hypothesis' explain how both poverty and wealth can be associated with HIV prevalence in sub-Saharan Africa?‏
670 ‎‡a Author's Dose finding for new vaccines: The role for immunostimulation/immunodynamic modelling‏
670 ‎‡a Author's Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007.‏
670 ‎‡a Author's Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study‏
670 ‎‡a Author's Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa‏
670 ‎‡a Author's Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results‏
670 ‎‡a Author's Estimating age-mixing patterns relevant for the transmission of airborne infections‏
670 ‎‡a Author's Estimation of the HIV basic reproduction number in rural south west Uganda: 1991-2008.‏
670 ‎‡a Author's Evaluation of respondent-driven sampling.‏
670 ‎‡a Author's Evaluation of the role of location and distance in recruitment in respondent-driven sampling.‏
670 ‎‡a Author's Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank.‏
670 ‎‡a Author's Exploratory space-time analyses of Rift Valley Fever in South Africa in 2008-2011‏
670 ‎‡a Author's Exploring the potential impact of a reduction in partnership concurrency on HIV incidence in rural Uganda: a modeling study‏
670 ‎‡a Author's Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.‏
670 ‎‡a Author's Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.‏
670 ‎‡a Author's Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models‏
670 ‎‡a Author's Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples‏
670 ‎‡a Author's History matching of a complex epidemiological model of human immunodeficiency virus transmission by using variance emulation‏
670 ‎‡a Author's HIV and STI prevalence and determinants among male migrant workers in India‏
670 ‎‡a Author's HIV incidence and recent injections among adults in rural southwestern Uganda‏
670 ‎‡a Author's HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention‏
670 ‎‡a Author's HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes‏
670 ‎‡a Author's How can mathematical models advance tuberculosis control in high HIV prevalence settings?‏
670 ‎‡a Author's Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route‏
670 ‎‡a Author's Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling‏
670 ‎‡a Author's Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries‏
670 ‎‡a Author's Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study‏
670 ‎‡a Author's Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention - a modelling study‏
670 ‎‡a Author's Improving the quality of modelling evidence used for tuberculosis policy evaluation‏
670 ‎‡a Author's Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status‏
670 ‎‡a Author's Infectiousness of HIV-infected homosexual men in the era of highly active antiretroviral therapy‏
670 ‎‡a Author's Links between premarital sexual behaviour and extramarital intercourse: a multi-site analysis‏
670 ‎‡a Author's Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia?‏
670 ‎‡a Author's Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa.‏
670 ‎‡a Author's Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?‏
670 ‎‡a Author's Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?‏
670 ‎‡a Author's Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity‏
670 ‎‡a Author's Mathematical models for the study of HIV spread and control amongst men who have sex with men.‏
670 ‎‡a Author's Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.‏
670 ‎‡a Author's Modelling the HIV epidemic among MSM in the United Kingdom: quantifying the contributions to HIV transmission to better inform prevention initiatives‏
670 ‎‡a Author's Mycobacterium tuberculosis transmission in an ethnically-diverse high incidence region in England, 2007-11‏
670 ‎‡a Author's Period and cohort dynamics in fertility norms at the onset of the demographic transition in Kenya 1978-1998.‏
670 ‎‡a Author's Periodic active case finding for TB: when to look?‏
670 ‎‡a Author's Polygyny and symmetric concurrency: comparing long-duration sexually transmitted infection prevalence using simulated sexual networks‏
670 ‎‡a Author's Population density, water supply, and the risk of dengue fever in Vietnam: cohort study and spatial analysis‏
670 ‎‡a Author's Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa‏
670 ‎‡a Author's Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis‏
670 ‎‡a Author's Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy‏
670 ‎‡a Author's Potential impact of tuberculosis vaccines in China, South Africa, and India‏
670 ‎‡a Author's Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy‏
670 ‎‡a Author's Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis‏
670 ‎‡a Author's Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.‏
670 ‎‡a Author's Quantifying HIV-1 transmission due to contaminated injections‏
670 ‎‡a Author's Regarding the effect of cured tuberculosis disease on longevity.‏
670 ‎‡a Author's Respondent driven sampling: determinants of recruitment and a method to improve point estimation‏
670 ‎‡a Author's Respondent driven sampling--where we are and where should we be going?‏
670 ‎‡a Author's Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines‏
670 ‎‡a Author's Rift Valley fever epidemiology, surveillance, and control: what have models contributed?‏
670 ‎‡a Author's Risk factors associated with Rift Valley fever epidemics in South Africa in 2008-11.‏
670 ‎‡a Author's Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis‏
670 ‎‡a Author's Self-clearance of <i>Mycobacterium tuberculosis</i> infection: implications for lifetime risk and population at-risk of tuberculosis disease‏
670 ‎‡a Author's Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis‏
670 ‎‡a Author's Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study.‏
670 ‎‡a Author's Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement‏
670 ‎‡a Author's Strong association between in-migration and HIV prevalence in urban sub-Saharan Africa‏
670 ‎‡a Author's Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines‏
670 ‎‡a Author's Systematic review of orogenital HIV-1 transmission probabilities‏
670 ‎‡a Author's The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis‏
670 ‎‡a Author's The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study‏
670 ‎‡a Author's The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.‏
670 ‎‡a Author's The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis‏
670 ‎‡a Author's The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.‏
670 ‎‡a Author's The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality‏
670 ‎‡a Author's The role of the natural epidemic dynamics and migration in explaining the course of the HIV epidemic in rural Uganda: a modelling study‏
670 ‎‡a Author's The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions‏
670 ‎‡a Author's Time for men to count, too.‏
670 ‎‡a Author's TIME Impact - a new user-friendly tuberculosis‏
670 ‎‡a Author's TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.‏
670 ‎‡a Author's To improve our tuberculosis burden estimates we need to learn from each other‏
670 ‎‡a Author's Towards elimination in industrialised countries: expanding diagnosis and treatment of LTBI among immigrants.‏
670 ‎‡a Author's Transmission events revealed in tuberculosis contact investigations in London.‏
670 ‎‡a Author's Transmission potential of Rift Valley fever virus over the course of the 2010 epidemic in South Africa.‏
670 ‎‡a Author's Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy‏
670 ‎‡a Author's Tuberculosis prevention in South Africa‏
670 ‎‡a Author's Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study‏
670 ‎‡a Author's Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa‏
670 ‎‡a Author's Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda‏
670 ‎‡a Author's Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination‏
670 ‎‡a Author's Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods‏
670 ‎‡a Author's Using the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality‏
670 ‎‡a Author's Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making‏
670 ‎‡a Author's Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study‏
670 ‎‡a Author's Wildlife-livestock interactions and risk areas for cross-species spread of bovine tuberculosis‏
909 ‎‡a (orcid) 0000000344106635‏ ‎‡9 1‏
919 ‎‡a tuberculosiscontrolinsouthafricangoldminesmathematicalmodelingofatrialofcommunitywideisoniazidpreventivetherapy‏ ‎‡A Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy‏ ‎‡9 1‏
919 ‎‡a transmissionpotentialofriftvalleyfevervirusoverthecourseofthe2010epidemicinsouthafrica‏ ‎‡A Transmission potential of Rift Valley fever virus over the course of the 2010 epidemic in South Africa.‏ ‎‡9 1‏
919 ‎‡a transmissioneventsrevealedintuberculosiscontactinvestigationsinlondon‏ ‎‡A Transmission events revealed in tuberculosis contact investigations in London.‏ ‎‡9 1‏
919 ‎‡a towardseliminationinindustrialisedcountriesexpandingdiagnosisandtreatmentofltbiamongimmigrants‏ ‎‡A Towards elimination in industrialised countries: expanding diagnosis and treatment of LTBI among immigrants.‏ ‎‡9 1‏
919 ‎‡a toimproveourtuberculosisburdenestimatesweneedtolearnfromeachother‏ ‎‡A To improve our tuberculosis burden estimates we need to learn from each other‏ ‎‡9 1‏
919 ‎‡a timeimpactanewuserfriendlytuberculosistbmodeltoinformtbpolicydecisions‏ ‎‡A TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.‏ ‎‡9 1‏
919 ‎‡a timeimpactanewuserfriendlytuberculosis‏ ‎‡A TIME Impact - a new user-friendly tuberculosis‏ ‎‡9 1‏
919 ‎‡a timeformentocounttoo‏ ‎‡A Time for men to count, too.‏ ‎‡9 1‏
919 ‎‡a tbvaccineh56+ic31doseresponsecurveispeakednotsaturatingdatagenerationfornewmathematicalmodellingmethodstoinformvaccinedosedecisions‏ ‎‡A The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions‏ ‎‡9 1‏
919 ‎‡a roleofthenaturalepidemicdynamicsandmigrationinexplainingthecourseofthehivepidemicinruralugandaamodellingstudy‏ ‎‡A The role of the natural epidemic dynamics and migration in explaining the course of the HIV epidemic in rural Uganda: a modelling study‏ ‎‡9 1‏
919 ‎‡a potentialimpactofbcgvaccinesupplyshortagesonglobalpaediatrictuberculosismortality‏ ‎‡A The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality‏ ‎‡9 1‏
919 ‎‡a potentialeffectsofchanginghivtreatmentpolicyontuberculosisoutcomesinsouthafricaresultsfrom3tuberculosishivtransmissionmodels‏ ‎‡A The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.‏ ‎‡9 1‏
919 ‎‡a impactofantiretroviraltherapyonmortalityinhivpositivepeopleduringtuberculosistreatmentasystematicreviewandmetaanalysis‏ ‎‡A The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis‏ ‎‡9 1‏
919 ‎‡a impactandcosteffectivenessofa4monthregimenfor1linetreatmentofactivetuberculosisinsouthafrica‏ ‎‡A The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.‏ ‎‡9 1‏
919 ‎‡a dualimpactofantiretroviraltherapyandsexualbehaviourchangesonhivepidemiologictrendsinugandaamodellingstudy‏ ‎‡A The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study‏ ‎‡9 1‏
919 ‎‡a distributionoffitnesscostsofresistanceconferringmutationsisakeydeterminantforthefutureburdenofdrugresistanttuberculosisamodelbasedanalysis‏ ‎‡A The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis‏ ‎‡9 1‏
919 ‎‡a systematicreviewoforogenitalhiv1transmissionprobabilities‏ ‎‡A Systematic review of orogenital HIV-1 transmission probabilities‏ ‎‡9 1‏
919 ‎‡a systematicreviewofmathematicalmodelsexploringtheepidemiologicalimpactoffuturetbvaccines‏ ‎‡A Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines‏ ‎‡9 1‏
919 ‎‡a strongassociationbetweeninmigrationandhivprevalenceinurbansubsaharanafrica‏ ‎‡A Strong association between in-migration and HIV prevalence in urban sub-Saharan Africa‏ ‎‡9 1‏
919 ‎‡a strengtheningthereportingofobservationalstudiesinepidemiologyforrespondentdrivensamplingstudiesstroberdsstatement‏ ‎‡A Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: "STROBE-RDS" statement‏ ‎‡9 1‏
919 ‎‡a smallcontributionofgoldminestotheongoingtuberculosisepidemicinsouthafricaamodelingbasedstudy‏ ‎‡A Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study.‏ ‎‡9 1‏
919 ‎‡a sexdifferencesintuberculosisburdenandnotificationsinlowandmiddleincomecountriesasystematicreviewandmetaanalysis‏ ‎‡A Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis‏ ‎‡9 1‏
919 ‎‡a selfclearanceof1mycobacteriumtuberculosis1infectionimplicationsforlifetimeriskandpopulationatriskoftuberculosisdisease‏ ‎‡A Self-clearance of <i>Mycobacterium tuberculosis</i> infection: implications for lifetime risk and population at-risk of tuberculosis disease‏ ‎‡9 1‏
919 ‎‡a riskofhiv1transmissionforparenteralexposureandbloodtransfusionasystematicreviewandmetaanalysis‏ ‎‡A Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis‏ ‎‡9 1‏
919 ‎‡a riskfactorsassociatedwithriftvalleyfeverepidemicsinsouthafricain200811‏ ‎‡A Risk factors associated with Rift Valley fever epidemics in South Africa in 2008-11.‏ ‎‡9 1‏
919 ‎‡a riftvalleyfeverepidemiologysurveillanceandcontrolwhathavemodelscontributed‏ ‎‡A Rift Valley fever epidemiology, surveillance, and control: what have models contributed?‏ ‎‡9 1‏
919 ‎‡a responsetypeandhostspeciesmaybesufficienttopredictdoseresponsecurveshapeforadenoviralvectorvaccines‏ ‎‡A Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines‏ ‎‡9 1‏
919 ‎‡a respondentdrivensamplingwhereweareandwhereshouldwebegoing‏ ‎‡A Respondent driven sampling--where we are and where should we be going?‏ ‎‡9 1‏
919 ‎‡a respondentdrivensamplingdeterminantsofrecruitmentandamethodtoimprovepointestimation‏ ‎‡A Respondent driven sampling: determinants of recruitment and a method to improve point estimation‏ ‎‡9 1‏
919 ‎‡a regardingtheeffectofcuredtuberculosisdiseaseonlongevity‏ ‎‡A Regarding the effect of cured tuberculosis disease on longevity.‏ ‎‡9 1‏
919 ‎‡a quantifyinghiv1transmissionduetocontaminatedinjections‏ ‎‡A Quantifying HIV-1 transmission due to contaminated injections‏ ‎‡9 1‏
919 ‎‡a proportionofnewhivinfectionsattributabletoherpessimplex2increasesovertimesimulationsofthechangingroleofsexuallytransmittedinfectionsinsubsaharanafricanhivepidemics‏ ‎‡A Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics.‏ ‎‡9 1‏
919 ‎‡a predictingthelongtermimpactofantiretroviraltherapyscaleuponpopulationincidenceoftuberculosis‏ ‎‡A Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis‏ ‎‡9 1‏
919 ‎‡a potentialpopulationlevelimpactontuberculosisincidenceofusinganmrnaexpressionsignaturecorrelateofrisktesttotargettuberculosispreventivetherapy‏ ‎‡A Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy‏ ‎‡9 1‏
919 ‎‡a potentialimpactoftuberculosisvaccinesinchinasouthafricaandindia‏ ‎‡A Potential impact of tuberculosis vaccines in China, South Africa, and India‏ ‎‡9 1‏
919 ‎‡a posttreatmenteffectofisoniazidpreventivetherapyontuberculosisincidenceinhivinfectedindividualsonantiretroviraltherapy‏ ‎‡A Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy‏ ‎‡9 1‏
919 ‎‡a populationlevelimpactofshortercourseregimensfortuberculosisamodelbasedanalysis‏ ‎‡A Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis‏ ‎‡9 1‏
919 ‎‡a populationleveleffectofpotentialhsv2prophylacticvaccinesonhivincidenceinsubsaharanafrica‏ ‎‡A Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa‏ ‎‡9 1‏
919 ‎‡a populationdensitywatersupplyandtheriskofdenguefeverinvietnamcohortstudyandspatialanalysis‏ ‎‡A Population density, water supply, and the risk of dengue fever in Vietnam: cohort study and spatial analysis‏ ‎‡9 1‏
919 ‎‡a polygynyandsymmetricconcurrencycomparinglongdurationsexuallytransmittedinfectionprevalenceusingsimulatedsexualnetworks‏ ‎‡A Polygyny and symmetric concurrency: comparing long-duration sexually transmitted infection prevalence using simulated sexual networks‏ ‎‡9 1‏
919 ‎‡a periodicactivecasefindingfortbwhentolook‏ ‎‡A Periodic active case finding for TB: when to look?‏ ‎‡9 1‏
919 ‎‡a periodandcohortdynamicsinfertilitynormsattheonsetofthedemographictransitioninkenya1978‏ ‎‡A Period and cohort dynamics in fertility norms at the onset of the demographic transition in Kenya 1978-1998.‏ ‎‡9 1‏
919 ‎‡a mycobacteriumtuberculosistransmissioninanethnicallydiversehighincidenceregioninengland200711‏ ‎‡A Mycobacterium tuberculosis transmission in an ethnically-diverse high incidence region in England, 2007-11‏ ‎‡9 1‏
919 ‎‡a modellingthehivepidemicamongmsmintheunitedkingdomquantifyingthecontributionstohivtransmissiontobetterinformpreventioninitiatives‏ ‎‡A Modelling the HIV epidemic among MSM in the United Kingdom: quantifying the contributions to HIV transmission to better inform prevention initiatives‏ ‎‡9 1‏
919 ‎‡a modelingofnoveldiagnosticstrategiesforactivetuberculosisasystematicreviewcurrentpracticesandrecommendations‏ ‎‡A Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.‏ ‎‡9 1‏
919 ‎‡a mathematicalmodelsforthestudyofhivspreadandcontrolamongstmenwhohavesexwithmen‏ ‎‡A Mathematical models for the study of HIV spread and control amongst men who have sex with men.‏ ‎‡9 1‏
919 ‎‡a mathematicalmodellingforoptimalvaccinedosefindingmaximisingefficacyandminimisingtoxicity‏ ‎‡A Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity‏ ‎‡9 1‏
919 ‎‡a malecircumcisionforhivpreventioninsubsaharanafricawhowhatandwhen‏ ‎‡A Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?‏ ‎‡9 1‏
919 ‎‡a malecircumcisionforhivpreventioninhighhivprevalencesettingswhatcanmathematicalmodellingcontributetoinformeddecisionmaking‏ ‎‡A Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?‏ ‎‡9 1‏
919 ‎‡a loweffectivenessofsyndromictreatmentservicesforcurablesexuallytransmittedinfectionsinruralsouthafrica‏ ‎‡A Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa.‏ ‎‡9 1‏
919 ‎‡a lookingupstreamtopreventhivtransmissioncaninterventionswithsexworkersalterthecourseofhivepidemicsinafricaastheydidinasia‏ ‎‡A Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia?‏ ‎‡9 1‏
919 ‎‡a linksbetweenpremaritalsexualbehaviourandextramaritalintercourseamultisiteanalysis‏ ‎‡A Links between premarital sexual behaviour and extramarital intercourse: a multi-site analysis‏ ‎‡9 1‏
919 ‎‡a infectiousnessofhivinfectedhomosexualmenintheeraofhighlyactiveantiretroviraltherapy‏ ‎‡A Infectiousness of HIV-infected homosexual men in the era of highly active antiretroviral therapy‏ ‎‡9 1‏
919 ‎‡a individuallevelfactorsassociatedwithvariationinmycobacterialspecificimmuneresponsegenderandpreviousbcgvaccinationstatus‏ ‎‡A Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status‏ ‎‡9 1‏
919 ‎‡a improvingthequalityofmodellingevidenceusedfortuberculosispolicyevaluation‏ ‎‡A Improving the quality of modelling evidence used for tuberculosis policy evaluation‏ ‎‡9 1‏
919 ‎‡a improvingartprogrammeretentionandviralsuppressionarekeytomaximisingimpactoftreatmentaspreventionamodellingstudy‏ ‎‡A Improving ART programme retention and viral suppression are key to maximising impact of treatment as prevention - a modelling study‏ ‎‡9 1‏
919 ‎‡a impactoftargetedtuberculosisvaccinationamongaminingpopulationinsouthafricaamodelbasedstudy‏ ‎‡A Impact of Targeted Tuberculosis Vaccination Among a Mining Population in South Africa: A Model-Based Study‏ ‎‡9 1‏
919 ‎‡a impactandcosteffectivenessofnewtuberculosisvaccinesinlowandmiddleincomecountries‏ ‎‡A Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries‏ ‎‡9 1‏
919 ‎‡a impactandcosteffectivenessofcurrentandfuturetuberculosisdiagnosticsthecontributionofmodelling‏ ‎‡A Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling‏ ‎‡9 1‏
919 ‎‡a immunologicdoseresponsetoadenovirusvectoredvaccinesinanimalsandhumansasystematicreviewofdoseresponsestudiesofreplicationincompetentadenoviralvaccinevectorswhengivenviaanintramuscularorsubcutaneousroute‏ ‎‡A Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route‏ ‎‡9 1‏
919 ‎‡a howcanmathematicalmodelsadvancetuberculosiscontrolinhighhivprevalencesettings‏ ‎‡A How can mathematical models advance tuberculosis control in high HIV prevalence settings?‏ ‎‡9 1‏
919 ‎‡a hivtreatmentaspreventionoptimisingtheimpactofexpandedhivtreatmentprogrammes‏ ‎‡A HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes‏ ‎‡9 1‏
919 ‎‡a hivtransmissionriskthroughanalintercoursesystematicreviewmetaanalysisandimplicationsforhivprevention‏ ‎‡A HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention‏ ‎‡9 1‏
919 ‎‡a hivincidenceandrecentinjectionsamongadultsinruralsouthwesternuganda‏ ‎‡A HIV incidence and recent injections among adults in rural southwestern Uganda‏ ‎‡9 1‏
919 ‎‡a hivandstiprevalenceanddeterminantsamongmalemigrantworkersinindia‏ ‎‡A HIV and STI prevalence and determinants among male migrant workers in India‏ ‎‡9 1‏
919 ‎‡a historymatchingofacomplexepidemiologicalmodelofhumanimmunodeficiencyvirustransmissionbyusingvarianceemulation‏ ‎‡A History matching of a complex epidemiological model of human immunodeficiency virus transmission by using variance emulation‏ ‎‡9 1‏
919 ‎‡a heterosexualhiv1infectiousnessandantiretroviralusesystematicreviewofprospectivestudiesofdiscordantcouples‏ ‎‡A Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples‏ ‎‡9 1‏
919 ‎‡a healthbenefitscostsandcosteffectivenessofearliereligibilityforadultantiretroviraltherapyandexpandedtreatmentcoverageacombinedanalysisof12mathematicalmodels‏ ‎‡A Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models‏ ‎‡9 1‏
919 ‎‡a globaltuberculosistargetsandmilestonessetfor20162035definitionandrationale‏ ‎‡A Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.‏ ‎‡9 1‏
919 ‎‡a feasibilityofachievingthe2025whoglobaltuberculosistargetsinsouthafricachinaandindiaacombinedanalysisof11mathematicalmodels‏ ‎‡A Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.‏ ‎‡9 1‏
919 ‎‡a exploringthepotentialimpactofareductioninpartnershipconcurrencyonhivincidenceinruralugandaamodelingstudy‏ ‎‡A Exploring the potential impact of a reduction in partnership concurrency on HIV incidence in rural Uganda: a modeling study‏ ‎‡9 1‏
919 ‎‡a exploratoryspacetimeanalysesofriftvalleyfeverinsouthafricain2008‏ ‎‡A Exploratory space-time analyses of Rift Valley Fever in South Africa in 2008-2011‏ ‎‡9 1‏
919 ‎‡a evidenceinformedpolicymakingatcountrylevellessonslearnedfromthesouthafricantuberculosisthinktank‏ ‎‡A Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank.‏ ‎‡9 1‏
919 ‎‡a evaluationoftheroleoflocationanddistanceinrecruitmentinrespondentdrivensampling‏ ‎‡A Evaluation of the role of location and distance in recruitment in respondent-driven sampling.‏ ‎‡9 1‏
919 ‎‡a evaluationofrespondentdrivensampling‏ ‎‡A Evaluation of respondent-driven sampling.‏ ‎‡9 1‏
919 ‎‡a estimationofthehivbasicreproductionnumberinruralsouthwestuganda1991‏ ‎‡A Estimation of the HIV basic reproduction number in rural south west Uganda: 1991-2008.‏ ‎‡9 1‏
919 ‎‡a estimatingagemixingpatternsrelevantforthetransmissionofairborneinfections‏ ‎‡A Estimating age-mixing patterns relevant for the transmission of airborne infections‏ ‎‡9 1‏
919 ‎‡a empiricalobservationsunderestimatetheproportionofhumanimmunodeficiencyvirusinfectionsattributabletosexuallytransmitteddiseasesinthemwanzaandrakaisexuallytransmitteddiseasetreatmenttrialssimulationresults‏ ‎‡A Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results‏ ‎‡9 1‏
919 ‎‡a empiricalestimationofresourceconstraintsforuseinmodelbasedeconomicevaluationanexampleoftbservicesinsouthafrica‏ ‎‡A Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa‏ ‎‡9 1‏
919 ‎‡a effectofpreexposureprophylaxisandcombinationhivpreventionformenwhohavesexwithmenintheukamathematicalmodellingstudy‏ ‎‡A Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study‏ ‎‡9 1‏
919 ‎‡a effectofhsv2onpopulationleveltrendsinhivincidenceinugandabetween1990and‏ ‎‡A Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007.‏ ‎‡9 1‏
919 ‎‡a dosefindingfornewvaccinestheroleforimmunostimulationimmunodynamicmodelling‏ ‎‡A Dose finding for new vaccines: The role for immunostimulation/immunodynamic modelling‏ ‎‡9 1‏
919 ‎‡a doestheinverseequityhypothesisexplainhowbothpovertyandwealthcanbeassociatedwithhivprevalenceinsubsaharanafrica‏ ‎‡A Does the 'inverse equity hypothesis' explain how both poverty and wealth can be associated with HIV prevalence in sub-Saharan Africa?‏ ‎‡9 1‏
919 ‎‡a dobehaviouraldifferenceshelptoexplainvariationsinhivprevalenceinadolescentsinsubsaharanafrica‏ ‎‡A Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa?‏ ‎‡9 1‏
919 ‎‡a determinantsofcoitalfrequencyamongmarriedwomenincentralafricanrepublictheroleoffemalegenitalcutting‏ ‎‡A Determinants of coital frequency among married women in Central African Republic: the role of female genital cutting‏ ‎‡9 1‏
919 ‎‡a coverageofclinicbasedtbscreeninginsouthafricamaybelowinkeyriskgroups‏ ‎‡A Coverage of clinic-based TB screening in South Africa may be low in key risk groups.‏ ‎‡9 1‏
919 ‎‡a costeffectivenessandresourceimplicationsofaggressiveactionontuberculosisinchinaindiaandsouthafricaacombinedanalysisof9models‏ ‎‡A Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models‏ ‎‡9 1‏
919 ‎‡a costandcosteffectivenessoftuberculosistreatmentshorteningamodelbasedanalysis‏ ‎‡A Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis‏ ‎‡9 1‏
919 ‎‡a correctiontosmallcontributionofgoldminestotheongoingtuberculosisepidemicinsouthafricaamodelingbasedstudy‏ ‎‡A Correction to: Small contribution of gold mines to the ongoing tuberculosis epidemic in South Africa: a modeling-based study‏ ‎‡9 1‏
919 ‎‡a concurrencyismorecomplexthanitseems‏ ‎‡A Concurrency is more complex than it seems‏ ‎‡9 1‏
919 ‎‡a comparisonofstdprevalencesinthemwanzarakaiandmasakatrialpopulationstheroleofselectionbiasanddiagnosticerrors‏ ‎‡A Comparison of STD prevalences in the Mwanza, Rakai, and Masaka trial populations: the role of selection bias and diagnostic errors.‏ ‎‡9 1‏
919 ‎‡a communityunderstandingofrespondentdrivensamplinginamedicalresearchsettinginugandaimportancefortheuseofrdsforpublichealthresearch‏ ‎‡A Community understanding of Respondent-Driven Sampling in a medical research setting in Uganda: importance for the use of RDS for public health research‏ ‎‡9 1‏
919 ‎‡a commentarywhatcanwemakeofanassociationbetweenhumanimmunodeficiencyvirusprevalenceandpopulationmobility‏ ‎‡A Commentary: What can we make of an association between human immunodeficiency virus prevalence and population mobility?‏ ‎‡9 1‏
919 ‎‡a choiceoftimehorizoncriticalinestimatingcostsandeffectsofchangestohivprogrammes‏ ‎‡A Choice of time horizon critical in estimating costs and effects of changes to HIV programmes.‏ ‎‡9 1‏
919 ‎‡a catastrophiccostspotentiallyavertedbytuberculosiscontrolinindiaandsouthafricaamodellingstudy‏ ‎‡A Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study‏ ‎‡9 1‏
919 ‎‡a canpopulationdifferencesexplainthecontrastingresultsofthemwanzarakaiandmasakahivsexuallytransmitteddiseaseinterventiontrialsamodelingstudy‏ ‎‡A Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study‏ ‎‡9 1‏
919 ‎‡a calibratingmodelsineconomicevaluationa7stepapproach‏ ‎‡A Calibrating models in economic evaluation: a seven-step approach.‏ ‎‡9 1‏
919 ‎‡a behaviourchangeandcompetitiveexclusioncanexplainthediverginghiv1andhiv2prevalencetrendsinguineabissau‏ ‎‡A Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau‏ ‎‡9 1‏
919 ‎‡a bayesianhistorymatchingofcomplexinfectiousdiseasemodelsusingemulationatutorialandacasestudyonhivinuganda‏ ‎‡A Bayesian history matching of complex infectious disease models using emulation: a tutorial and a case study on HIV in Uganda‏ ‎‡9 1‏
919 ‎‡a attemptingtoexplainheterogeneoushivepidemicsinsubsaharanafricapotentialroleofhistoricalchangesinriskbehaviourandmalecircumcision‏ ‎‡A Attempting to explain heterogeneous HIV epidemics in sub-Saharan Africa: potential role of historical changes in risk behaviour and male circumcision‏ ‎‡9 1‏
919 ‎‡a attainingrealisticandsubstantialreductionsinhivincidencemodelprojectionsofcombiningmicrobicideandmalecircumcisioninterventionsinruraluganda‏ ‎‡A Attaining realistic and substantial reductions in HIV incidence: model projections of combining microbicide and male circumcision interventions in rural Uganda‏ ‎‡9 1‏
919 ‎‡a applicationofprovincialdatainmathematicalmodellingtoinformsubnationaltuberculosisprogramdecisionmakinginsouthafrica‏ ‎‡A Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa‏ ‎‡9 1‏
919 ‎‡a antiretroviraltreatmentcohortanalysisusingtimeupdatedcd4countsassessmentofbiaswithdifferentanalyticmethods‏ ‎‡A Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methods‏ ‎‡9 1‏
919 ‎‡a antiretroviraltherapyandsexualbehaviorinugandaacohortstudy‏ ‎‡A Antiretroviral therapy and sexual behavior in Uganda: a cohort study‏ ‎‡9 1‏
919 ‎‡a explanationforthelowproportionoftuberculosisthatresultsfromtransmissionbetweenhouseholdandknownsocialcontacts‏ ‎‡A An explanation for the low proportion of tuberculosis that results from transmission between household and known social contacts.‏ ‎‡9 1‏
919 ‎‡a evaluationoftuberculosiscontactinvestigationsagainstnationalstandards‏ ‎‡A An evaluation of tuberculosis contact investigations against national standards‏ ‎‡9 1‏
919 ‎‡a amplifiedhivtransmissionduringearlystageinfection‏ ‎‡A Amplified HIV Transmission during Early‐Stage Infection‏ ‎‡9 1‏
919 ‎‡a agetargetedtuberculosisvaccinationinchinaandimplicationsforvaccinedevelopmentamodellingstudy‏ ‎‡A Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study‏ ‎‡9 1‏
919 ‎‡a acceleratingprogresstowardstuberculosiseliminationtheneedforcombinationtreatmentandprevention‏ ‎‡A Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention‏ ‎‡9 1‏
919 ‎‡a abilityofpreventivetherapytocurelatentmycobacteriumtuberculosisinfectioninhivinfectedindividualsinhighburdensettings‏ ‎‡A Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings‏ ‎‡9 1‏
919 ‎‡a systematicreviewofpublishedrespondentdrivensamplingsurveyscollectingbehavioralandbiologicdata‏ ‎‡A A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data.‏ ‎‡9 1‏
919 ‎‡a networklevelexplanationforthedifferencesinhivprevalenceinsouthafricasracialgroups‏ ‎‡A A network-level explanation for the differences in HIV prevalence in South Africa's racial groups‏ ‎‡9 1‏
919 ‎‡a multistrainmathematicalmodeltoinvestigatetheroleofpyrazinamideintheemergenceofextensivelydrugresistanttuberculosis‏ ‎‡A A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis‏ ‎‡9 1‏
919 ‎‡a bayesianapproachtounderstandingsexdifferencesintuberculosisdiseaseburden‏ ‎‡A A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease Burden‏ ‎‡9 1‏
919 ‎‡a wildlifelivestockinteractionsandriskareasforcrossspeciesspreadofbovinetuberculosis‏ ‎‡A Wildlife-livestock interactions and risk areas for cross-species spread of bovine tuberculosis‏ ‎‡9 1‏
919 ‎‡a validationofahostbloodtranscriptomicbiomarkerforpulmonarytuberculosisinpeoplelivingwithhivaprospectivediagnosticandprognosticaccuracystudy‏ ‎‡A Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study‏ ‎‡9 1‏
919 ‎‡a usingvaccineimmunostimulationimmunodynamicmodellingmethodstoinformvaccinedosedecisionmaking‏ ‎‡A Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making‏ ‎‡9 1‏
919 ‎‡a usingthetimemodelinspectrumtoestimatetuberculosishivincidenceandmortality‏ ‎‡A Using the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality‏ ‎‡9 1‏
919 ‎‡a usingdatafrommacaquestopredictgammainterferonresponsesaftermycobacteriumbovisbcgvaccinationinhumansaproofofconceptstudyofimmunostimulationimmunodynamicmodelingmethods‏ ‎‡A Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods‏ ‎‡9 1‏
919 ‎‡a updatingagespecificcontactstructurestomatchevolvingdemographyinadynamicmathematicalmodeloftuberculosisvaccination‏ ‎‡A Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination‏ ‎‡9 1‏
919 ‎‡a universaltesttreatandkeepimprovingartretentioniskeyincosteffectivehivcontrolinuganda‏ ‎‡A Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda‏ ‎‡9 1‏
919 ‎‡a understandingtheimpactofmalecircumcisioninterventionsonthespreadofhivinsouthernafrica‏ ‎‡A Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa‏ ‎‡9 1‏
919 ‎‡a understandingthedifferencesbetweencontrastinghivepidemicsineastandwestafricaresultsfromasimulationmodelofthe4citiesstudy‏ ‎‡A Understanding the differences between contrasting HIV epidemics in east and west Africa: results from a simulation model of the Four Cities Study‏ ‎‡9 1‏
919 ‎‡a tuberculosispreventioninsouthafrica‏ ‎‡A Tuberculosis prevention in South Africa‏ ‎‡9 1‏
943 ‎‡a 199x‏ ‎‡A 1998‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2011‏ ‎‡9 1‏
943 ‎‡a 200x‏ ‎‡A 2008‏ ‎‡9 2‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 ISNI|0000000075641153‏
996 ‎‡2 ISNI|0000000384869127‏
996 ‎‡2 DNB|140965572‏
996 ‎‡2 J9U|987007440201105171‏
996 ‎‡2 RERO|A021960962‏
996 ‎‡2 B2Q|0001546053‏
996 ‎‡2 BNF|17837441‏
996 ‎‡2 SUDOC|136678688‏
996 ‎‡2 BIBSYS|90318879‏
996 ‎‡2 LC|nb 91102458‏
996 ‎‡2 LC|n 89605658‏
996 ‎‡2 ISNI|0000000090165386‏
996 ‎‡2 SUDOC|028438221‏
996 ‎‡2 ISNI|0000000083799022‏
996 ‎‡2 BNF|14453666‏
996 ‎‡2 J9U|987007422911905171‏
996 ‎‡2 SUDOC|161795617‏
996 ‎‡2 BNF|12410839‏
996 ‎‡2 BIBSYS|1090726‏
996 ‎‡2 SUDOC|22762114X‏
996 ‎‡2 J9U|987007369136705171‏
996 ‎‡2 ISNI|000000038711028X‏
996 ‎‡2 ISNI|0000000059118610‏
996 ‎‡2 LC|n 88620515‏
996 ‎‡2 NII|DA09232479‏
996 ‎‡2 DNB|1128106167‏
996 ‎‡2 B2Q|0000091236‏
996 ‎‡2 BNF|13525292‏
996 ‎‡2 NII|DA12885368‏
996 ‎‡2 LC|n 2009078384‏
996 ‎‡2 ISNI|0000000038182576‏
996 ‎‡2 DNB|134018702‏
996 ‎‡2 NTA|202014258‏
996 ‎‡2 LC|no2011143710‏
996 ‎‡2 LC|n 2003038263‏
996 ‎‡2 LC|n 95052204‏
996 ‎‡2 BIBSYS|90105388‏
996 ‎‡2 ISNI|0000000436141884‏
996 ‎‡2 LC|no2012115009‏
996 ‎‡2 LC|nr 96013894‏
996 ‎‡2 ISNI|0000000083593948‏
996 ‎‡2 NUKAT|n 2010121140‏
996 ‎‡2 LC|nr 95025217‏
996 ‎‡2 PLWABN|9810675900105606‏
996 ‎‡2 J9U|987007270984705171‏
996 ‎‡2 J9U|987007290922405171‏
996 ‎‡2 CAOONL|ncf10122746‏
996 ‎‡2 CAOONL|ncf10003780‏
996 ‎‡2 LC|n 85195838‏
996 ‎‡2 ISNI|0000000119989179‏
996 ‎‡2 BIBSYS|90184612‏
996 ‎‡2 LC|no2023009943‏
996 ‎‡2 LC|n 83126594‏
996 ‎‡2 ISNI|0000000079961269‏
996 ‎‡2 CAOONL|ncf11272203‏
996 ‎‡2 LC|n 87908040‏
996 ‎‡2 BIBSYS|90136471‏
996 ‎‡2 NUKAT|n 2009117904‏
996 ‎‡2 LC|no2014107489‏
996 ‎‡2 JPG|500072073‏
996 ‎‡2 ISNI|0000000030506310‏
996 ‎‡2 LC|n 94116453‏
996 ‎‡2 CAOONL|ncf10137032‏
996 ‎‡2 NLA|000035823319‏
996 ‎‡2 J9U|987011436910405171‏
996 ‎‡2 LC|n 82073711‏
996 ‎‡2 RERO|A022838392‏
996 ‎‡2 LC|no 97061966‏
996 ‎‡2 LC|n 84025076‏
996 ‎‡2 BIBSYS|90083805‏
996 ‎‡2 BIBSYS|3104434‏
996 ‎‡2 LC|nb2010024589‏
996 ‎‡2 NUKAT|n 2014001463‏
996 ‎‡2 LC|n 85368185‏
996 ‎‡2 SIMACOB|175530083‏
996 ‎‡2 ISNI|0000000053696102‏
996 ‎‡2 LC|nb2010008258‏
996 ‎‡2 CAOONL|ncf11544969‏
996 ‎‡2 RERO|A013405402‏
996 ‎‡2 ISNI|0000000088125756‏
996 ‎‡2 LC|n 2017066091‏
996 ‎‡2 N6I|vtls000361584‏
996 ‎‡2 ISNI|0000000424495458‏
996 ‎‡2 NTA|067591175‏
996 ‎‡2 NTA|070047057‏
996 ‎‡2 J9U|987007347205805171‏
996 ‎‡2 NTA|072526629‏
996 ‎‡2 ISNI|0000000074855598‏
996 ‎‡2 ISNI|0000000025266324‏
996 ‎‡2 BIBSYS|90674286‏
996 ‎‡2 BIBSYS|1634281494110‏
996 ‎‡2 DNB|1090282788‏
996 ‎‡2 DNB|1050185390‏
996 ‎‡2 NTA|068295847‏
996 ‎‡2 DNB|134026241‏
996 ‎‡2 J9U|987007430463405171‏
996 ‎‡2 BNE|XX1001005‏
996 ‎‡2 SUDOC|114986290‏
996 ‎‡2 ISNI|0000000438635554‏
996 ‎‡2 SUDOC|079275885‏
996 ‎‡2 ISNI|0000000005088196‏
996 ‎‡2 LC|n 81089171‏
996 ‎‡2 ISNI|0000000385757709‏
996 ‎‡2 CAOONL|ncf10951893‏
996 ‎‡2 BIBSYS|6081531‏
996 ‎‡2 NUKAT|n 2020102252‏
996 ‎‡2 BAV|495_39373‏
996 ‎‡2 BAV|495_39375‏
996 ‎‡2 DNB|1035491273‏
996 ‎‡2 J9U|987007440025005171‏
996 ‎‡2 BNF|17706844‏
996 ‎‡2 LC|n 83160744‏
996 ‎‡2 JPG|500189578‏
996 ‎‡2 BIBSYS|90183091‏
996 ‎‡2 RERO|A024111042‏
996 ‎‡2 ISNI|0000000023342290‏
996 ‎‡2 LC|n 82065124‏
996 ‎‡2 BIBSYS|1615358754451‏
996 ‎‡2 NTA|069904987‏
996 ‎‡2 NLA|000035940818‏
996 ‎‡2 ISNI|0000000026457712‏
996 ‎‡2 ISNI|0000000033314701‏
996 ‎‡2 NII|DA11974291‏
996 ‎‡2 ISNI|0000000380378283‏
996 ‎‡2 SUDOC|188176489‏
996 ‎‡2 ISNI|0000000121270147‏
996 ‎‡2 NII|DA01188872‏
996 ‎‡2 ISNI|0000000046728436‏
996 ‎‡2 ISNI|0000000026541607‏
996 ‎‡2 ISNI|0000000445337459‏
996 ‎‡2 NTA|323974139‏
996 ‎‡2 RERO|A013405440‏
996 ‎‡2 NDL|00957305‏
996 ‎‡2 LC|no2001026982‏
996 ‎‡2 DNB|134150963X‏
996 ‎‡2 BNF|14238886‏
996 ‎‡2 ISNI|000000008267421X‏
996 ‎‡2 CAOONL|ncf11282778‏
996 ‎‡2 NTA|082529973‏
996 ‎‡2 LC|no2004078531‏
996 ‎‡2 LC|nb2010024576‏
996 ‎‡2 NLA|000035793889‏
996 ‎‡2 BIBSYS|90102269‏
996 ‎‡2 RERO|A014141300‏
996 ‎‡2 J9U|987007370903105171‏
996 ‎‡2 LC|n 81001989‏
996 ‎‡2 LC|n 78001634‏
996 ‎‡2 NKC|ola2008452180‏
996 ‎‡2 DNB|136833330‏
996 ‎‡2 ISNI|000000004017150X‏
996 ‎‡2 LC|n 87804087‏
996 ‎‡2 SUDOC|191783420‏
996 ‎‡2 BIBSYS|90780959‏
996 ‎‡2 ISNI|0000000082757402‏
996 ‎‡2 RERO|A022818062‏
996 ‎‡2 ISNI|0000000078949399‏
996 ‎‡2 J9U|987007446789405171‏
996 ‎‡2 LC|n 87103683‏
996 ‎‡2 ISNI|0000000453075858‏
996 ‎‡2 ISNI|0000000031321633‏
996 ‎‡2 ISNI|0000000082313158‏
996 ‎‡2 ISNI|0000000072979714‏
996 ‎‡2 BIBSYS|90232308‏
996 ‎‡2 ISNI|0000000083241811‏
996 ‎‡2 N6I|vtls002482570‏
996 ‎‡2 J9U|987007376373405171‏
996 ‎‡2 CAOONL|ncf10147994‏
996 ‎‡2 ISNI|0000000498027198‏
996 ‎‡2 SUDOC|127432647‏
996 ‎‡2 NUKAT|n 2021006061‏
996 ‎‡2 NTA|100311709‏
996 ‎‡2 LC|n 85166604‏
996 ‎‡2 LC|n 82013790‏
996 ‎‡2 J9U|987007335611105171‏
996 ‎‡2 BNF|15589719‏
996 ‎‡2 N6I|vtls000313788‏
996 ‎‡2 SUDOC|242562183‏
996 ‎‡2 NLA|000035732936‏
996 ‎‡2 SUDOC|203156714‏
996 ‎‡2 LC|no2019055901‏
996 ‎‡2 LC|no2002082956‏
996 ‎‡2 DNB|134018664‏
996 ‎‡2 BNF|15589980‏
996 ‎‡2 J9U|987007318455205171‏
996 ‎‡2 DNB|173384536‏
996 ‎‡2 ISNI|0000000499633093‏
996 ‎‡2 ISNI|0000000067518980‏
996 ‎‡2 SUDOC|06012153X‏
996 ‎‡2 ISNI|0000000072857725‏
996 ‎‡2 ISNI|0000000080249789‏
996 ‎‡2 NLA|000035671871‏
996 ‎‡2 J9U|987012385036405171‏
996 ‎‡2 CAOONL|ncf10286666‏
996 ‎‡2 ISNI|0000000120508301‏
996 ‎‡2 J9U|987007339548605171‏
996 ‎‡2 LC|n 2007076465‏
996 ‎‡2 LC|n 85023158‏
996 ‎‡2 J9U|987007331058005171‏
996 ‎‡2 BNF|11608003‏
996 ‎‡2 ISNI|0000000025320968‏
996 ‎‡2 SUDOC|227357108‏
996 ‎‡2 BNF|12536380‏
996 ‎‡2 ISNI|0000000045462234‏
996 ‎‡2 DNB|140597654‏
996 ‎‡2 DNB|119466716‏
996 ‎‡2 LC|n 2002101886‏
996 ‎‡2 LC|n 88617110‏
996 ‎‡2 J9U|987012747983405171‏
996 ‎‡2 LC|no2023036716‏
996 ‎‡2 BIBSYS|90553373‏
996 ‎‡2 LC|n 83055894‏
996 ‎‡2 LC|nb2008022693‏
996 ‎‡2 BIBSYS|12053939‏
996 ‎‡2 LC|nr 92037605‏
996 ‎‡2 LC|no2009056070‏
996 ‎‡2 ISNI|0000000082671692‏
996 ‎‡2 LC|nb2010024185‏
996 ‎‡2 LC|n 88617432‏
996 ‎‡2 SUDOC|176919538‏
996 ‎‡2 LC|nb2010024597‏
996 ‎‡2 BNE|XX1015189‏
996 ‎‡2 LC|n 2010183627‏
996 ‎‡2 LC|nr 93010908‏
996 ‎‡2 RERO|A013405437‏
996 ‎‡2 NSK|000189510‏
996 ‎‡2 RERO|A003971685‏
996 ‎‡2 RERO|A003971684‏
996 ‎‡2 RERO|A003971681‏
996 ‎‡2 NTA|145314820‏
996 ‎‡2 RERO|A003971683‏
996 ‎‡2 RERO|A003971682‏
996 ‎‡2 PLWABN|9810655292805606‏
996 ‎‡2 LC|n 2009005222‏
996 ‎‡2 ISNI|0000000052907393‏
996 ‎‡2 LC|n 93067395‏
996 ‎‡2 ISNI|0000000029726033‏
996 ‎‡2 N6I|vtls000274932‏
996 ‎‡2 ISNI|0000000030307303‏
996 ‎‡2 LC|n 88636077‏
996 ‎‡2 DNB|1089874383‏
996 ‎‡2 BIBSYS|3005718‏
996 ‎‡2 NII|DA11461639‏
996 ‎‡2 BIBSYS|10010383‏
996 ‎‡2 NDL|00477141‏
996 ‎‡2 PLWABN|9812665901605606‏
996 ‎‡2 LC|no 00070944‏
996 ‎‡2 LC|nr 96029294‏
996 ‎‡2 LC|no2011084277‏
996 ‎‡2 LC|n 85215663‏
996 ‎‡2 ISNI|0000000409023954‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏